Stabilization of the H5 clade 2.3.4.4b hemagglutinin improves vaccine-elicited neutralizing antibody responses in mice
Authors:
- Annie DoseyADAnnie Dosey
- Bernadeta DadonaiteBDBernadeta Dadonaite
- Rebecca A. GillespieRGRebecca A. Gillespie
- Elizabeth M. LeafELElizabeth M. Leaf
- Matthew J. VukovichMVMatthew J. Vukovich
- Jackson McGowanJMJackson McGowan
- Emily GreyEGEmily Grey
- Hiromi MuramatsuHMHiromi Muramatsu
- Rachel H. J. JunRJRachel H. J. Jun
- Norbert PardiNorbert Pardi
- Masaru KanekiyoMKMasaru Kanekiyo
- Jesse D. BloomJBJesse D. Bloom
- 4 March 2026
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 18 (839) , eaea8770
Abstract
Transmission of highly pathogenic avian influenza from H5 clade 2.3.4.4b has expanded in recent years to infect large populations of birds and mammals, heightening the risk of a human pandemic. Influenza viruses that are adapted to transmission in birds and a variety of mammals tend to have a less stable hemagglutinin (HA) than seasonal influenza viruses, enabling membrane fusion at comparatively higher pH levels. Here, we combined five mutations in the H5 HA that increased its melting temperature and promoted stable closure of the HA trimer. Structural analysis by cryo–electron microscopy revealed that the stabilizing mutations create several new hydrophobic interactions while maintaining the local HA structure. We found that vaccinating mice with stabilized H5 HA immunogens resulted in higher hemagglutination inhibition and neutralization titers than nonstabilized comparators. Epitope mapping of vaccine-elicited polyclonal antibody responses using negative-stain electron microscopy and deep mutational scanning showed that site E on the side of the HA receptor binding domain was immunodominant across all groups; however, the stabilized immunogens shifted responses toward the receptor binding site, which elicited a higher proportion of neutralizing antibodies. Consistent with these findings, stabilized H5 HA immunogens delivered as messenger RNA–lipid nanoparticle (mRNA-LNP) vaccines protected mice against H5N1 challenge. These findings highlight that H5 HA–stabilizing mutations enhance the quality of antibody responses across different vaccine formats, underscoring their potential to improve pandemic preparedness vaccines targeting viruses from this widely circulating clade.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (U19 AI181881)
This publication has 62 references indexed in Scilit:
- A pseudovirus system enables deep mutational scanning of the full SARS-CoV-2 spikeCell, 2023
- Virus vaccines: proteins prefer prolinesCell Host & Microbe, 2021
- A Site of Vulnerability on the Influenza Virus Hemagglutinin Head Domain Trimer InterfaceCell, 2019
- Slow Delivery Immunization Enhances HIV Neutralizing Antibody and Germinal Center Responses via Modulation of ImmunodominanceCell, 2019
- Immune history and influenza virus susceptibilityCurrent Opinion in Virology, 2017
- Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodiesNature, 2013
- An overview of the epidemiology of avian influenzaVaccine, 2007
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- SerialEM: A Program for Automated Tilt Series Acquisition on Tecnai Microscopes Using Prediction of Specimen PositionMicroscopy and Microanalysis, 2003
- Studies of the Binding Properties of Influenza Hemagglutinin Receptor-Site MutantsVirology, 1998